PEN (Penumbra Inc) Company Net Income

Official company branding of penumbrainc.com (PEN)

Geopolitical tensions and disruptions in Asian electronics supplies are creating operational challenges for Penumbra, Inc. (PEN). This profit chart illustrates current dynamics, where the 0.16 level indicates the parameter's status. Unique US-based production capacities for vascular devices ensure business stability, while the global scaling of innovative thrombectomy catheters effectively increases the company's net margin.

Penumbra Inc (PEN) Net Income: for the period 07/04/2022 - 10/31/2026

Financial and market metric breakdowns for Penumbra (PEN)

- current price and projected stock value:
Quote Chart Penumbra Medical|PEN - Analyst Consensus Forecast
- business market valuation indicators:
Market Value Penumbra Medical|PEN - Real Price to Acquire Entire Company
- balance sheet equity data:
Book Value per Share Penumbra|PEN - Company Net Assets|Market Cap to Book Value Multiple penumbrainc.com|PEN - Company Total Assets
- debt and solvency information:
Total Debt to Capital Coefficient Penumbra, Inc.|PEN - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Penumbra Inc|PEN - Company Total Debt|Debt to Net Assets Ratio Penumbra Medical|PEN - Company Long-Term Debt|Company Current Liabilities Penumbra|Immediate Liquidity penumbrainc.com
- earnings and market multiples details:
PEN - Net Profit
Summary company analysis:Penumbra Medical (PEN)
Mass-produced product of Penumbra Corp

Analyzing real cash flow is critical for minimizing risks in long-term investing. At Penumbra, Inc. (PEN), the efficiency of robotic catheter production must offset high R&D expenses and neurosurgeon compensation. By analyzing the company's profit, an investor can observe the daily balance between operating costs and market demand. This metric allows for the diagnosis of financial imbalances prior to official reports. Steady growth of this indicator confirms the resilience of the business model.

Main competitors

Profit After Tax DXCM (Dexcom CGM)|NOVT (Novanta Inc.) - Net Profit|Company Net Income haemonetics.com HAE|Net Income INSP (Inspire Medical Systems, Inc.)|Net Profit PROCEPT BioRobotics Corp (PRCT)|CONMED Corp. - Net Income|Profit After Payment of Taxes PLSE (Pulse Medical)|InMode Ltd. - Net Profit|Net Financial Result picardmedical.com PMI|SRDX: Net Profit|Net Income Eversense|Net Income NPCE|TCMD: Final Profit|Company Net Income Sanuwave Health Inc (SNWV)|Net Income outsetmedical.com OM|Net Profit ELMD (Electromed)|LENSAR Inc. (LNSR) - Company Net Income|AVITA Medical, Inc - Net Profit|PROF (Profound Medical Corp.) - Company Profit|BDMD: Net Profit|EDAP - Net Financial Result|APYX (Apyx Medical Corp) - Net Profit|Net Income IceCure Medical, Ltd. (ICCM)|Net Profit LUNG|Net Profit telabio.com (TELA)|Company Net Income CytoSorbents Corporation CTSO|sensushealthcare.com - Company Net Income|ZYXI: Net Income|Final Profit ECOR (electroCore, Inc.)|RBOT: Net Profit|Company Net Income Inspira Technologies (IINN)|Company Net Income SeaStar Medical Holding|IRIX - Annual Net Income|Net Income INBS (Intelligent Bio Solutions)|Net Profit beyondair.net (XAIR)|Net Profit PFSA (Profusa, Inc.)|Net Financial Result STRATA Skin Sciences Inc. (SSKN)|GCTK - Company Net Income|Profit After Tax NAOV|Venus Concept (VERO) - Company Net Income|Net Income Nuwellis Inc|AEMD (Aethlon) - Net Profit|Company Net Income TransEnterix ASXC|Company Net Income Avinger, Inc. (AVGR)|BioSig - Company Profit|Cutera - Net Income|Profit After Payment of Taxes KNW (Know Labs Inc)|NARI - Company Net Income|Profit After Tax NVRO|RSLS: Net Profit|Company Net Income silkroadmed.com (SILK)